Carly Ching, Ph.D., is a USP Quality Institute Fellow in the Quality of Medical Products at Boston University. Working under the mentorship of Muhammad Zaman, Ph.D., Dr. Ching’s research seeks to determine the extent to which substandard antibiotics contribute to antibiotic resistance acquisition. It is hypothesized that the use of substandard drugs will not only be less effective against bacteria, but also drive acquisition of antibiotic resistance. Importantly, Dr. Ching’s work aims to elucidate the social and genetic mechanisms by which substandard medicines may impact antibiotic resistance, in order to support evidence-based policy changes. Dr. Ching’s mentors also include Veronika Wirtz, Ph.D., of Boston University’s School of Public Health, and Kevin Carrick, Ph.D., of USP.
Prior to this fellowship, Dr. Ching earned her Ph.D. in Biology at Northeastern University. Her doctoral research focused on stress responses in the opportunistic bacterial pathogen Acinetobacter baumannii, a leading cause of multi-drug resistant hospital-acquired infections. This work identified novel regulatory elements and physiological responses to stress in A. baumannii.